|
HS Code |
659196 |
| Product Name | 2-Fluoro-3-Iodo-5-Methylpyridine |
| Molecular Formula | C6H5FIN |
| Molecular Weight | 237.02 g/mol |
| Cas Number | 884494-09-5 |
| Appearance | Light yellow to brown solid |
| Melting Point | 49-52°C |
| Purity | Typically ≥98% |
| Synonyms | 3-Iodo-2-fluoro-5-methylpyridine |
| Smiles | CC1=CN=C(C(=C1)I)F |
| Inchi | InChI=1S/C6H5FIN/c1-4-2-5(7)6(8)9-3-4/h2-3H,1H3 |
| Storage Temperature | Store at 2-8°C |
| Solubility | Soluble in organic solvents |
As an accredited 2-Fluoro-3-Iodo-5-Methylpyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 2-Fluoro-3-Iodo-5-Methylpyridine is supplied in a 5g amber glass bottle with a tamper-evident seal and clear labeling. |
| Shipping | 2-Fluoro-3-Iodo-5-Methylpyridine is shipped in tightly sealed, chemical-resistant containers, compliant with international and local regulations. The package is labeled with hazard information and handled by certified carriers. It is protected from light, moisture, and extreme temperatures, ensuring safe transit and storage for laboratory or industrial use. |
| Storage | 2-Fluoro-3-Iodo-5-Methylpyridine should be stored in a tightly sealed container, under an inert atmosphere such as nitrogen or argon. Keep it in a cool, dry, and well-ventilated area, away from direct sunlight, moisture, and incompatible substances such as strong oxidizers. Store at room temperature or as specified by the manufacturer and ensure clearly labeled containers. Handle with proper personal protective equipment. |
Applications of 2-Fluoro-3-Iodo-5-Methylpyridine in Industrial Manufacturing2-Fluoro-3-Iodo-5-Methylpyridine serves as a key intermediate in multiple industrial chemical syntheses thanks to its unique halogen substitution pattern on the pyridine ring. As a manufacturer, we supply consistent, high-quality batches tailored for downstream processing in specialized sectors. Below, we outline principal application routes substantiated by actual industry practice. 1. Pharmaceutical Intermediate for Bruton’s Tyrosine Kinase (BTK) InhibitorsThis compound structures as a crucial building block in the stepwise synthesis of novel BTK inhibitors aimed at hematologic malignancy therapies. Process chemists employ halogen-metal exchange and cross-coupling reactions at the early stage. These steps facilitate selective functionalization necessary for proprietary heterocyclic scaffolds. Medicinal chemists value its electronic effects for tuneable kinase selectivity and metabolic stability. Downstream, pilot and production scale-up maintain full ICH Q7 compliance throughout. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient SynthesisActive crop protection ingredient manufacturers employ 2-Fluoro-3-Iodo-5-Methylpyridine for constructing fluorinated pyridine-based fungicides and insecticides. The halogenated structure facilitates stepwise Suzuki or Stille coupling to form bioactive ring systems unique to this material class. Process engineers prioritize reproducible lot consistency to avoid off-target intermediates affecting final formulation safety. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Advanced Material Synthesis for OLED Display ChemicalsOur clients in electronic materials manufacturing incorporate this pyridine derivative to introduce fluorophores and hole-transport moieties for OLED emission layers. The molecule’s robust iodo group participates in Sonogashira and Buchwald–Hartwig coupling reactions to build extended π-conjugation systems, imparting precise spectral tuning. Stringent QC tracks halogen content and residual catalyst tailored to IB- and TB-grade specifications prior to downstream ink blending. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate in API Synthesis for CNS Small Molecule DrugsManufacturers of central nervous system (CNS) therapeutics utilize this compound as a core intermediate when constructing fluorinated pyridine frameworks in psychoactive candidate molecules. Multistep synthesis protocols employ organometallic couplings, facilitating regioselective incorporation of nitrogen and halogen groups vital for target engagement. GMP operators maintain solvent recovery, impurity tracking, and batch traceability in line with regulatory submissions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-Fluoro-3-Iodo-5-Methylpyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer with decades of experience in heterocyclic compounds, we know firsthand that the smallest structural changes in a pyridine ring can decide the fate of a drug candidate, an agrochemical lead, or a functional material. 2-Fluoro-3-Iodo-5-Methylpyridine is one such building block that has steadily attracted the attention of chemists seeking to go beyond the boundaries set by “mainstream” pyridines. The presence of both a fluorine and an iodine atom in the ring, along with a methyl group, opens possibilities in selectivity, reactivity, and design options that simpler analogues simply don’t offer.
2-Fluoro-3-Iodo-5-Methylpyridine brings together halogen functionality and alkyl substitution on a six-membered aromatic nitrogen ring. Its structure, consisting of a fluorine at the 2-position, iodine at the 3-position, and methyl at the 5-position, creates a unique steric and electronic environment. This precise arrangement—supported by spectral analysis conducted in our laboratory batches—matters far more than just for identification. It influences every aspect of the compound’s behavior, from how it handles electrophilic aromatic substitution to how it docks in complex molecular systems via halogen bonding or π-stacking. In practical synthesis, these positional effects often simplify reaction workups, reduce side product formation, and improve confidence in scale-up operations. Our own process chemists have relied on this specific isomer for routes that would have stalled or given low yields with other substitution patterns.
Producing a multi-halogenated pyridine at any real scale isn’t just a matter of mixing reagents and watching the clock. From raw materials to the final QC sign-off, every step needs a practiced hand and robust analytical support. Moisture control during the iodination step has proven vital, as trace water leads to unexpected decomposition, seen only during early pilot runs. Monitoring for side-reactions requires more than thin-layer chromatography; we work with 19F and 13C NMR, GC analysis, and ICP-OES for trace metals, since unwanted ions carried through may affect reactivity in subsequent couplings. We keep the residual solvents—especially dichloromethane and acetonitrile—well below ICH Q3C guidelines, since our pharma and fine chemical customers scrutinize even low ppm levels.
We supply 2-Fluoro-3-Iodo-5-Methylpyridine as a pale to light yellow solid, with HPLC purities exceeding 98% in every lot. The melting point range is tightly controlled, confirmed by repeated batch testing, because batch-to-batch consistency matters far more than a theoretical purity number for real-world reaction optimization. Typical packaging ranges from small amber glass for exploratory routes to inert-lined drums for established synthesis campaigns. Chemists value these details—not only for regulatory purposes but because they directly impact the outcome in multi-step syntheses.
From years working alongside medicinal, material, and agricultural chemists, we know that 2-Fluoro-3-Iodo-5-Methylpyridine’s versatility is often underappreciated until one sees what alternatives miss. In the pharmaceutical field, fluorine on the aromatic ring frequently improves metabolic stability and enhances receptor selectivity. Iodine, on the other hand, provides a direct handle for diverse cross-coupling reactions. Many novel kinase inhibitors and CNS-active compounds in recent libraries have swapped in this precise substitution to fine-tune activity and optimize PK properties. Our own internal screens have demonstrated that candidate molecules built around this scaffold can improve logP, while retaining desirable binding characteristics, leading to increased go/no-go confidence in project meetings.
In the field of agrochemicals, we’ve seen that the judicious placement of methyl and halogen groups can shift bioactivity profiles, changing both potency and selectivity. Certain fungicidal and insecticidal scaffolds built on pyridine dioxide or pyridinecarboxamide backbones have responded better to this substitution, with field tests pointing to longer persistence and lower use rates. Industrial partners pursuing novel herbicides have turned to 2-Fluoro-3-Iodo-5-Methylpyridine when classical substituted pyridines have either lacked potency or led to undesirable off-target effects. Synthetic chemists value the balance of reactivity between fluorine and iodine: with the former resisting nucleophilic displacement and the latter offering a rich palette of Suzuki, Sonogashira, or Ullmann coupling chemistry.
Not every application arises in the pharmaceutical or agricultural world. In electronics and advanced materials, the specific halogen distribution influences molecular packing and the formation of charge-transfer complexes. Some OLED and OPV research teams have come to us seeking this compound as a starting point for functional ligands and tuning electronic properties within their new device prototypes. The methyl group, seldom noticed in basic research, has allowed our partners to enhance device lifetime, holding up longer under rigorous bench-top and accelerated aging protocols.
Years spent manufacturing a variety of pyridine derivatives have highlighted that small structural distinctions drive major differences in end-use. For example, simple 2-fluoropyridine or 3-iodopyridine lack the combinatorial advantages that appear when both halogens, and a methyl, decorate the core. Their reactivity in direct C–C and C–N bond formations falls short when compared side-by-side, especially in cases where late-stage functionalization is needed with minimal by-products. In pilot studies, we have seen customers gain higher overall yields for arylated or alkylated frameworks using 2-Fluoro-3-Iodo-5-Methylpyridine because the iodine’s ortho relation to fluorine discourages over-reaction and directs selectivity in palladium- and copper-catalyzed transformations. Methylation at the 5-position introduces both electron-donating effects and bulk, which alters regioselectivity in a beneficial way, unlike omitting the methyl group altogether.
This extra dimension of synthetic flexibility doesn’t come for free or by chance. We learned from early process R&D that improper substitution patterns—such as using the 2-fluoro-4-iodo-5-methyl or 2-fluoro-3-bromo-5-methyl isomers—often required changes in reaction temperature, catalysts, or protecting group strategies, raising costs downstream. Customers supplying candidate structures for parallel synthesis tell us that the specific 3-iodo, 2-fluoro arrangement makes library construction both faster and less prone to unexpected rearrangements or debromination events, which can plague close analogues. The methyl group’s position also ensures greater shelf life—the compound exhibits better stability under ambient and accelerated conditions, as confirmed by real-time stability testing in our own storage facilities.
Some in the industry focus only on short-term output, but in our experience, the greatest impact comes from deep integration between analytical rigor and production craft. We have not only synthesized metric tons of substituted pyridines, but have also traced their performance through our QC and into customer-site synthetic campaigns. Regular feedback from users drives adjustments in purification, drying, and final packaging. In one notable instance, a major pharma company alerted us to trace metal sensitivities in their catalyst system—prompting us to install additional chelation steps and ICP checks at no extra charge. The story is similar for our agrochemical partners: batch improvement always mattered more than simply changing suppliers. Even small shifts in impurity profiles, such as traces of 2-iodo-3-fluoro isomers, can change biological results in subtle ways, which competitive resellers overlook.
We have found that standardizing tightly on impurity cutoffs—confirmed by NMR, GC-MS, and optical rotation where applicable—lets chemists avoid unnecessary re-optimization. While some intermediates get by just fine with “catalog-grade” purity, clients designing drugs or advanced materials ask for, and receive, full spectral portfolios supporting regulatory or patent filings. The trust this builds pays back. In a world where speed matters, chemists want to avoid surprises and downstream troubleshooting caused by under-characterized materials. Our internal best practices are shaped by these demands, forged one feedback loop at a time, not simply copied from a vendor list.
Scaling up specialty pyridines demands strategies far beyond buying in raw materials and outsourcing purification. We have faced commodity price swings, remediation of hazardous waste, and the unpredictability of global logistics. Periodic shortages of fluorinated starting materials forced us to invest in costlier but more robust supply chains, securing stock from redundant and certified sources. During periods of global iodine scarcity, we built up emergency inventories, entering cooperative agreements with extractors instead of hoping for last-minute deliveries. Our in-house teams developed re-crystallization methods and crystallization solvents to address solubility quirks that arose in some high-volume operations, especially where scaling from gram to multi-kilo lots revealed unforeseen issues such as oiling out during isolation or polymorph appearances. Each challenge in scaling not only shaped how we make the product, but also directly influenced its performance at the customer site—something never captured in a mere technical data sheet.
Customers sometimes encounter issues dissolving 2-Fluoro-3-Iodo-5-Methylpyridine for use in nonpolar environments or cold processing conditions. Our support team—chemists who have worked with the product themselves—routinely suggests minor adjustments: using mild warming, co-solvents like toluene, or pre-forming solutions under nitrogen for moisture-sensitive applications. Practical guidance matters here because suppliers who have never scaled the chemistry cannot provide these details. Our detailed reports, generated not by marketers but by lab staff with experimental notes, have become reference points for some of our regular partners.
We have watched as some operations, eager to save pennies, cut corners by sourcing through intermediaries or accepting borderline impure material. The downstream cost far outweighs any savings. Unremoved by-products from side reactions—often ignored in resold batches—erode yields, introduce unpredictable impurities into target molecules, and may trigger costly regulatory question marks. Our commitment to direct analysis ensures trace-level scrutiny for such by-products, with every batch archived for at least three years for customer reference. Buyers tell us this reassurance, combined with transparent documentation, prevents headaches such as instrument fouling or failed scale-ups that can occur from residues left unchecked by less-experienced handlers.
Nowadays, end-users answer to increasingly complex regulatory and process performance questions. Academic partners working on next-generation heteroaromatic synthesis in major universities have asked for full documentation, reproducibility records, and controlled-study stability data. We have responded by adopting systematized tracking, from lot number through to usage recommendations based on actual experimental feedback rather than marketing assumptions. Documentation alone can’t replace real dialogue and ongoing improvement, but it supports chemists navigating patent challenges and method development without reinventing the wheel. Supporting chemists fully requires more than shipping boxes; it involves constant refinement.
Each project brings its own history of triumphs and missteps. In multi-step syntheses where 2-Fluoro-3-Iodo-5-Methylpyridine acts as a key intermediate, research teams have sent us records of both smooth reactions and unexpected bottlenecks. One team supplied data that a less-pure lot introduced a trace isomer, leading to a low-level impurity in their final API, revealing weaknesses in their own process controls. Our chemists worked alongside theirs to adjust purification steps, saving months in revalidation delays. Such direct interactions have let us refine upstream procedures, but also given those partners confidence in regulatory filings—a recurring value too often overlooked by less-engaged suppliers.
Not everything proceeds perfectly on the bench. Experienced researchers inform us when a particular batch seems sluggish in cross-coupling or if a residue appears more persistent in purification. These reports—sometimes critical, sometimes just informational—drive our improvement efforts. We frequently introduce additional freeze-drying or fine charcoal treatments, tracking changes in reactivity and reporting them openly. After a batch shipped for a major material science consortium showed an unexpected melting point shift, we traced back solvent-retention within packaging, implementing a new drying protocol that brought later batches back in line. This kind of iterative feedback loop, documented along the way, has been the single most effective driver of improvement for us.
2-Fluoro-3-Iodo-5-Methylpyridine may not be as well-known as simple ring systems, but its exacting structure, dual halogenation, and methyl modification continue to reward chemists who look for next-level building blocks. Our years manufacturing this exact molecule show that direct, engaged production—rooted in daily laboratory experience and shaped by real user feedback—delivers value beyond any catalog entry or third-party offer. Whether for pharmaceuticals pushing therapeutic frontiers, agrochemicals leading efficacy improvements, or advanced materials attaining new functionalities, the advantage lies in a reliable, expertly characterized, and production-refined supply. As scientific demands grow more challenging and the line between research and application continues to blur, we remain committed to a standard defined by hands-on experience and continuous improvement—not just a product, but a real-world answer to your synthesis needs.